Risk factors for failure to detect a cancer during clinical breast examinations (United States)

Cancer Causes and Control

Volumn 14, Issue 5, 2003, Pages 461-468

  Bobo, Janet Kay ^a,b   Lawson, Herschel W ^a   Lee, Nancy C ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b BATTELLE MEMORIAL INSTITUTE   (United States)

Author keywords

Breast; Cancer; Professional practice; Screening

Indexed keywords

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BREAST BIOPSY; BREAST CANCER; BREAST EXAMINATION; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; SYMPTOMATOLOGY; TUMOR VOLUME; UNITED STATES;

ADULT; AGED; BIOPSY; BREAST NEOPLASMS; COMMUNITY HEALTH SERVICES; DIAGNOSTIC ERRORS; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; ODDS RATIO; PALPATION; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 0041732176     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024904104286     Document Type: Article

References (28)

1. Barton MB, Harris R, Fletcher SW (1999) Does this patient have breast cancer? The screening clinical breast examination: should it be done? How? JAMA 282: 1270-1280.
2. Miller AB, To T, Baines CJ, Wall C (2000) Canadian national breast screening study-2: 13 year results of a randomized trial in women aged 50-59 years. JNCI 92: 1490-1499.
3. US Preventive Services Task Force (1996) Guide to Clinical Preventive Services. 2nd edn. Baltimore: Williams & Wilkins.
4. Humphrey L, Helfand M, Chan B, Woolf SH (2002) Breast cancer screening: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 137: 347-360.
5. Blackman DK, Bennet EM, Miller DS (1999) Trends in self-reported use of mammograms (1989-1997) and Papanicolaou tests (1991-1997) - Behavioral Risk Factor Surveillance System. MMWR 48: 1-22.
6. National Committee for Quality Assurance (1997) HEDIS 3.0/1998: Narrative - What's in it and Why it Matters. Vol. 1, Washington. D.C: National Committee for Quality Assurance, pp. 1-3.
7. Fletcher SW (2000) Following up abnormal breast cancer screening results: lessons for primary care clinicians. J Am Board Fam Pract 13: 152-154.
8. American College of Radiology (1995) Breast Imaging Reporting and Data System (BI-RADS). 2nd edn. Reston, VA: American College of Radiology.
9. Bobo JK, Lee NC, Thames SF (2000) Findings from 752,081 clinical breast examinations reported to a National Screening Program from 995 through 1998. JNCI 92: 971-976.
10. Yang Q, Khoury MJ, Sun F, Flanders WD (1999) Case-only design to measure gene-gene interaction. Epidemiology 10: 167-170.
11. Begg CB, Zhang Z (1994) Statistical analysis of molecular epidemiology studies employing case-series. Cancer Epidemiol Biomarkers Prevention 3: 173-175.
12. Coates R, Uhler RJ, Brogan DJ, et al. (2001) Patterns and predictors of the beast cancer detection methods in women under 45 years of age (US). Cancer Causes Control 12: 431-442.
13. Farrington CP, Nash J, Miller E (1996) Case-series analysis of adverse reactions to vaccines: a comparative evaluation. AJE 143: 1165-1173.
14. McCarthy N, Gift Hc (1999) Case-case comparisons to study causation of common infectious diseases. Int J Biomed Comput 28: 764-768.
15. Henson RM, Wyatt SW, Lee NC (1996) The National Breast and Cervical Cancer Early Detection Program: a comprehensive public health response to two major health issues for women. J Public Health Manage Prac 2(2): 36-47.
16. May DS, Lee NC, Nadel MR, Henson RM, Miller DS (1998) The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women. Am J Roentol 170: 97-104.
17. American joint committee on cancer (1992) Manual for the Staging of Cancer. 4th edn. Philadelphia: Lippincott.
18. Surveillance, Epidemiology, and End Results Program (1986) Summary Staging Guide. Washington DC: US Department of Health and Human Services.
19. Fleiss JL (1981) Statistical Methods for Rates and Proportions. 2nd edn. New York: John Wiley & Sons.
20. Breslow NE, Day NE (1992) Statistical Methods in Cancer Research. Vol. II. International Agency for Research on Cancer.
21. Maclure M, Greenland S (1992) Tests for trend and dose response: misinterpretation and alternatives. Am J Epidemiol 135: 96-104.
22. Eddy DM (1989) Screening for breast cancer. Ann Int Med 111: 389-399.
23. Oestreicher N, White E, Lehman C, Mandelson MT, Porter P, Taplin S (2002) Predictors of sensitivity of clinical breast examination (CBE). Breast Cancer Res Treat 76: 73-81.
24. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW (1998) Ten-year risk of false positive screening mammograms and clinical breast examinations. NEJM 338: 1089-1096.
25. Leppert PC (1997) The importance of the gynecologic examination. In: Leppert PC, Howard FM, eds. Primary Care for Women, Philadelphia: Lippincott-Raven, pp. 25-29.
26. Pennypacker HS, Naylor L, Sander AA, Goldstein MS (1999) Why can't we do better breast examinations? Nurse Pract Forum 10: 122-128.
27. Henderson BE, Pike MC, Bernstein L, Ross RL (1996) Breast cancer. In: Schottenfeld D, Fraumeni Jr JF, eds. Cancer Epidemiology and Prevention, New York: Oxford, pp. 1022-1039.
28. Egglin TKP, Feinstein AR (1996) Context bias - A problem in diagnostic radiology. JAMA 276: 1752-1755.